Literature DB >> 26076605

Activation of RAW 264.7 cells by a polysaccharide isolated from Antarctic bacterium Pseudoaltermonas sp. S-5.

Jing Li1, Wen Qian2, Yanghui Xu2, Guochuang Chen3, Guodong Wang2, Songliu Nie4, Bingxiang Shen4, Zhigang Zhao2, Chunyan Liu2, Kaoshan Chen5.   

Abstract

The aim of this study was to examine the effect of extracellular polysaccharide (PEP) from Antarctic bacterium Pseudoaltermonas sp. S-5 on RAW 264.7 cells together with the underlying signaling pathways. Our results illustrated that PEP induced dendritic-like morphological change in RAW 264.7 cells, and increased the productions of nitric oxide (NO) and tumor necrosis factor-α (TNF-α). PEP could also enhance phagocytic activity of RAW 264.7 cells. Results of immunofluorescence staining and immunoblotting indicated that PEP caused the nuclear translocation of nuclear factor (NF)-κB subunit p65, the degradation of IκB-α and up-expression of phosphorylated p38 mitogen-activated protein kinase (MAPK) in RAW 264.7 cells. According to pharmacological evaluation with specific enzyme inhibitors, both NF-κB and p38 MAPK signaling pathways were involved in the generation of NO and TNF-α induced by PEP. All these results indicated that PEP from Antarctic bacterium Pseudoaltermonas sp. S-5 activated RAW 264.7 cells through NF-κB and p38 MAPK signaling pathways.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antarctic bacterium Pseudoaltermonas sp. S-5; Extracellular polysaccharide; Immunostimulatory activity; Nuclear factor-κB; p38 MAPK

Mesh:

Substances:

Year:  2015        PMID: 26076605     DOI: 10.1016/j.carbpol.2015.04.070

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  8 in total

1.  Statistical Optimization of Novel Medium to Maximize the Yield of Exopolysaccharide From Lacticaseibacillus rhamnosus ZFM216 and Its Immunomodulatory Activity.

Authors:  Liang Chen; Qing Gu; Tao Zhou
Journal:  Front Nutr       Date:  2022-06-02

2.  Tumor-Treating Fields Induce RAW264.7 Macrophage Activation Via NK-κB/MAPK Signaling Pathways.

Authors:  Jeong-In Park; Kyung-Hee Song; Seung-Youn Jung; Jiyeon Ahn; Sang-Gu Hwang; Joon Kim; Eun Ho Kim; Jie-Young Song
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

3.  Exopolysaccharide from Paecilomyces lilacinus modulates macrophage activities through the TLR4/NF‑κB/MAPK pathway.

Authors:  Chao He; Hai-Yan Lin; Cai-Chun Wang; Ming Zhang; Ying-Ying Lin; Feng-Ying Huang; Ying-Zi Lin; Guang-Hong Tan
Journal:  Mol Med Rep       Date:  2019-10-15       Impact factor: 2.952

4.  SBT (Composed of Panax ginseng and Aconitum carmichaeli) and Stigmasterol Enhances Nitric Oxide Production and Exerts Curative Properties as a Potential Anti-Oxidant and Immunity-Enhancing Agent.

Authors:  Na-Ra Han; Kyeoung-Cheol Kim; Ju-Sung Kim; Hi-Joon Park; Seong-Gyu Ko; Phil-Dong Moon
Journal:  Antioxidants (Basel)       Date:  2022-01-20

5.  Lactobacillus plantarum RS-09 Induces M1-Type Macrophage Immunity Against Salmonella Typhimurium Challenge via the TLR2/NF-κB Signalling Pathway.

Authors:  Chenpei Zhao; Huan Chen; Hao Liang; Xiaoyu Zhao; Wenli Tang; Maolian Wei; Youzhi Li; Jianlong Zhang; Xin Yu; Guozhong Chen; Hongwei Zhu; Linlin Jiang; Xingxiao Zhang
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

6.  Zeb1 regulation of wound-healing-induced inflammation in alkali-damaged corneas.

Authors:  Wei Liang; Yingnan Zhang; Liang Zhou; Xiaoqin Lu; Margaret E Finn; Wei Wang; Hui Shao; Douglas C Dean; Lijun Zhang; Yongqing Liu
Journal:  iScience       Date:  2022-03-08

7.  Immunostimulatory activity of soybean hull polysaccharide on macrophages.

Authors:  Mengxue Wang; Chenye Fu; Mingcong Zhang; Yuxian Zhang; Liang Cao
Journal:  Exp Ther Med       Date:  2022-04-12       Impact factor: 2.447

8.  Polysaccharides from Polygonatum sibiricum Delar. ex Redoute induce an immune response in the RAW264.7 cell line via an NF-κB/MAPK pathway.

Authors:  Jiaozhen Zhang; Na Liu; Chao Sun; Deqing Sun; Yongjie Wang
Journal:  RSC Adv       Date:  2019-06-07       Impact factor: 4.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.